23andMe Holding Co.
ME · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.00 | 0.03 | 0.04 |
| FCF Yield | -21.30% | -220.77% | -53.81% | -24.61% |
| EV / EBITDA | -4.64 | -1.16 | -3.33 | -2.35 |
| Quality | ||||
| ROIC | -38.58% | -226.60% | -6.58% | -33.11% |
| Gross Margin | 53.23% | 38.79% | 66.09% | 50.84% |
| Cash Conversion Ratio | 1.22 | 0.41 | 0.84 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | -16.07% | -14.09% | -12.13% | -13.41% |
| Free Cash Flow Growth | 31.11% | 8.54% | -5.60% | 2.09% |
| Safety | ||||
| Net Debt / EBITDA | 0.48 | -0.71 | 0.94 | 1.05 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.89 | 1.78 | 0.95 | 1.46 |
| Cash Conversion Cycle | 0.96 | 74.31 | 110.64 | 85.44 |